XSHE
002626
Market cap1.65bUSD
Feb 24, Last price
18.90CNY
1Q
1.61%
Jan 2017
36.07%
IPO
162.96%
Name
Xiamen Kingdomway Group Co
Chart & Performance
P/E
33.71
P/S
3.56
EPS
0.56
Div Yield, %
2.14%
Shrs. gr., 5y
—
Rev. gr., 5y
0.30%
Revenues
3.24b
+4.43%
Net income
342m
+23.59%
CFO
521m
-21.57%
Dividend
Jun 20, 20250.4 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health resources in China and internationally. It offers a series of raw material products, including coenzyme Q10, Vitamin A, Vitamin D3, microalgae DHA, and plant ARA, as well as provides dietary supplements and sports nutrition products. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd. Xiamen Kingdomway Group Company was founded in 1997 and is based in Xiamen, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||